Özlem Türeci
Gründer bei BIONTECH SE
Vermögen: 79 Mio $ am 30.04.2024
Aktive Positionen von Özlem Türeci
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIONTECH SE | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | - |
| Gründer | 02.06.2008 | - | |
| Association For Cancer Immunotherapy | Präsident | - | - |
| Direktor/Vorstandsmitglied | - | - | |
| Ci3 Management UG | Vorsitzender | - | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - | - |
Karriereverlauf von Özlem Türeci
Ehemalige bekannte Positionen von Özlem Türeci
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Vorstandsvorsitzender | 01.01.2008 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | - | |
| Gründer | 01.01.2001 | - |
Ausbildung von Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Statistik
International
| Deutschland | 7 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG | |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
- Börse
- Insiders
- Özlem Türeci
- Erfahrung
